Full-Time

Clinical Data Engineer

Pharma/CRO

MMS

MMS

1,001-5,000 employees

Regulatory compliance and data solutions provider

No salary listed

Remote in India

Remote

Bachelor's

Category
Data & Analytics (1)
Required Skills
Python
SAS
Data Visualization
R
SQL
Data Modeling
Data Analysis
Google Cloud Platform

Get referred to MMS

See people who can refer or advise you

Requirements
  • A bachelor's degree in life sciences, statistics, data engineering, computer science, or a related field, or equivalent experience.
  • At least 5 years of experience in data engineering or a related discipline, preferably within clinical research or a contract research organization environment.
  • Intermediate proficiency in Structured Query Language and Python, with working knowledge of Statistical Analysis System and R.
  • Strong understanding of clinical trial processes, protocols, case report form data, and Clinical Data Interchange Standards Consortium standards, including Study Data Tabulation Model and Analysis Data Model.
  • Ability to mentor team members and collaborate cross-functionally.
  • Strong analytical, organizational, and communication skills.
Responsibilities
  • Apply data modeling best practices to transform source data into governed common data models.
  • Incorporate data warehouse concepts, including star schemas, to support dashboard reporting and implement data lineage strategies for auditability and inspection readiness.
  • Develop intermediate Transact-SQL stored procedures and use window functions, common table expressions, derived tables, and dynamic Transact-SQL.
  • Optimize and tune complex queries and data processing workflows for performance and scalability.
  • Refactor software for reuse, apply design patterns, encapsulate logic, and minimize side effects.
  • Lead enterprise-level mapping strategies that transform raw clinical data into standardized Clinical Data Interchange Standards Consortium-compliant formats.
  • Maintain governance of Study Data Tabulation Model and Analysis Data Model structures across studies.
  • Design scalable validation frameworks to detect systemic data issues.
  • Prepare, correct, modify, and analyze large, complex datasets using advanced analytical techniques to ensure integrity and traceability.
  • Maintain understanding of Good Clinical Practice, FDA 21 CFR Part 11, and evolving regulatory guidance as they apply to data curation deliverables.
  • Establish documentation standards, audit trail governance, and inspection-ready processes.
  • Deliver curated, high-quality datasets to analytics platforms to enable real-time dashboards and operational key performance indicators.
  • Support internal and external stakeholders through engineering tools and solutions.
Desired Qualifications
  • Experience as a Clinical Data Engineer or Programmer in a contract research organization.
  • Experience supporting integrated risk planning and management initiatives.

MMS Holdings is a global contract research organization (CRO) focused on regulatory compliance and data-driven solutions for pharmaceutical and biotech sponsors. It delivers services such as regulatory submissions, clinical trial management, data analytics, and medical writing through a service-based model that relies on established processes and experienced advisors. Its work is contract-based, often long-term, aimed at helping clients meet regulatory requirements, run trials efficiently, and advance therapies under FDA guidance. The company differentiates itself with a science-first approach, a strong track record (97% client satisfaction), and involvement in complex areas like enabling MDMA-assisted therapy research, underscoring a commitment to high-quality, compliant outcomes for sponsors globally.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Canton, Ohio

Founded

2006

Get referred to MMS

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Datacise reached ACDM finalist status in January 2026, validating MMS's software strategy.
  • West Coast expansion before BIO 2026 targets venture-backed biotechs and faster sponsor acquisition.
  • I-ACT and pediatric-trials partnerships broaden MMS's therapeutic footprint and referral network.

What critics are saying

  • MMS still depends on sponsor-funded biotech budgets; trial delays hit revenue fast in 2026.
  • Private-equity ownership under Lindsay Goldberg pushes margin discipline before culture and retention.
  • Ascendancy in biometrics invites competition from IQVIA, Parexel, and Medidata on bigger accounts.

What makes MMS unique

  • Exploristics acquisition added KerusCloud and deep biostatistics, strengthening MMS's data science edge.
  • Ben Dudley became President in May 2026, sharpening global commercial and scientific execution.
  • Former FDA leaders Somya Dunn and other advisors deepen MMS's regulatory credibility.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

20%

1 year growth

20%

2 year growth

20%
MMS Holdings
Feb 12th, 2025
MMS Acquires Exploristics for Data Science Expansion

MMS, a clinical research organization, has acquired Exploristics, a biostatistics and data science company. This acquisition enhances MMS' capabilities in advanced clinical trial design and data science, integrating Exploristics' KerusCloud® platform. The move expands MMS' global presence, particularly in Europe, and aims to optimize drug development strategies, reducing time and costs. Exploristics' CEO, Aiden Flynn, joins MMS as Senior VP, Head of Strategic Statistical Consulting.

TipRanks
Jan 29th, 2024
Orgenesis Inc Strikes Definitive Deal to Acquire Octomera LLC

On January 29, 2024, Orgenesis Inc. acquired all equity interests in Octomera LLC from MM OS Holdings, L.P., an affiliate of Metalmark Capital.

MMS Holdings
Apr 18th, 2023
MMS Named Great Place To Work In The UK

MMS Holdings Inc. plan to expand and grow in the UK and Europe to build on its teams and deliver value to its clients”

Applied Clinical Trials
Apr 14th, 2023
People and Business News – 4/23

EmVenio Research announced the appointment of Mark Mackenzie, MD, as chief medical officer.

Business Wire
Mar 21st, 2023
MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise | Business Wire

MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors.